Purchases and Sales Made in Q3 2022 in Olema Pharmaceuticals, Inc. (OLMA)
This table provides information about the institutional ownership of Olema Pharmaceuticals, Inc. (OLMA) during Q3 2022. The information is specifically focused on institutions that hold shares of Olema Pharmaceuticals, Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Nov 14, 2022
Q3 2022
|
Newtyn Management, LLC
New York, NY |
SELL
|
- |
-100K- 20.0% |
$272K - $588K
|
400K
$2.41M
|
|
|
Nov 14, 2022
Q3 2022
|
Charles Schwab Investment Management Inc
San Francisco, CA |
SELL
|
- |
-119K- 86.46% |
$323K - $698K
|
18.6K
$112K
|
|
|
Nov 14, 2022
Q3 2022
|
David A. Siegel
Two Sigma Advisers, LP | New York, Ny
|
SELL
|
- |
-129K- 25.17% |
$352K - $760K
|
385K
$2.31M
|
|
|
Nov 14, 2022
Q3 2022
|
Morgan Stanley
New York, NY |
SELL
|
- |
-149K- 34.12% |
$405K - $876K
|
288K
$1.73M
|
|
|
Nov 14, 2022
Q3 2022
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
SELL
|
- |
-228K- 15.41% |
$621K - $1.34M
|
1.25M
$7.54M
|
|
|
Nov 09, 2022
Q3 2022
|
Fairmount Funds Management LLC
Philadelphia, PA |
SELL
|
- |
-1.44M- 53.86% |
$3.91M - $8.45M
|
1.23M
$7.41M
|